-
Govt takes control of Turkey's most-watched news channel
-
Bournemouth boss Rose urges Cherries to bounce back from Chelsea 'slap'
-
FIFA to offer members $6.35-billion development fund windfall
-
Top seed Sabalenka falls at first hurdle in Wuhan
-
US consumer inflation hotter than expected as midterms loom
-
FX Junction Brings Copy Trading to Everyone, While Their Money Never Leaves With Their Broker
-
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro
-
Brighton defender Struijk's red card overturned
-
Hot US inflation data dents Wall Street stocks
-
Saudi league postpones three matches after Houthi attacks
-
India sends 'cockroach' leaders to jail after protest
-
US consumer inflation up more than expected as midterms loom
-
'Sinners' director Ryan Coogler to reboot 'X-Files' for Disney
-
Canadian publisher supports novelist Orelien after AI denial
-
Lufthansa wins contest for TAP Air Portugal stake
-
Medvedev sees off Tsitsipas to reach Shanghai Masters quarters
-
AI worms, 'major' incident fears spur safety calls at industry summit
-
Louvre boss warns of closure risk without major renovations
-
Fuel shortage triggers queues on Indonesia's Bali island
-
Lawes and Genge urge England to end ban on overseas-based players
-
Evolution Metals & Technologies Corp. Reaffirms $400 Million to $460 Million FY2027 Revenue Guidance, Unveils Eight Sintered Magnet Grades Covering an Estimated 75% of Global NdFeB Revenue, and Moves to Answer U.S. Army Call for Rare Earth Magnets
-
Metrika Selected by OCC to Support Stablecoin Supervisory Framework Under the GENIUS Act
-
Trial defence says Russia used Nord Stream pipelines as 'weapon'
-
Kenya hosting 2029 World Championships will help doping fight, says Coe
-
Israeli settlers set fire to mosque in occupied West Bank
-
UK prosecutor tells jury Russell Brand a 'sexual predator'
-
Macron says French student protesters 'exploited' by political forces: spokeswoman
-
Fulham manager Arbeloa fined £25,000 after Man Utd outburst
-
Stocks diverge ahead of key US inflation data
-
Nepal flood triggered by rock and ice avalanche: report
-
Japan summons Russian ambassador to protest journalist's arrest
-
'Distressed' family of UK man killed by tiger urge end to online posts
-
Workers to strike at world's largest copper mine in Chile
-
Regulator expects Man City appeal to be heard by January
-
Ukraine accuses US of helping Russia as missiles hit Kyiv
-
Rising Spanish tennis star handed code violation for swearing at ballboy
-
Drone hits data centre of Russia's largest bank
-
Last of the French musketeers Monfils officially retired from tennis
-
Bivial AG Brings Its Complete Dashboard to Mobile
-
Ukraine ex-military officer stands trial over Nord Stream sabotage
-
Mont Blanc nearly two metres taller than in 2023: French surveyors
-
British and Irish Lions to play first women's match against France
-
Pope recovering after lung cancer operation that rattles Church
-
Fuel shortage triggers queues on resort island Bali
-
Indonesia haze spikes Singapore pollution, shuts East Timor schools
-
Sao Tome's niche vanilla finds far-away fans
-
Higher borrowing costs an 'alarm signal' for France: finance minister
-
China-North Korea bridge to open Thursday, 12 years late
-
Zelensky accuses Putin of disrespecting Trump after latest attacks
-
Asian stocks mostly down as tech firms struggle to claw back losses
Olympus CEO resigns over alleged illegal drugs purchase
The German CEO of major Japanese optical equipment manufacturer Olympus has stepped down after allegedly buying illegal drugs, the company said on Monday.
Stefan Kaufmann became chief executive officer in April 2023, having served as a board member since 2019. He first joined the European arm of Olympus in 2003.
Olympus shares plunged six percent in morning trade as the company apologised in a statement "for the concern this has caused to our shareholders, customers and all stakeholders".
"Upon receiving an allegation that Mr Stefan Kaufmann had purchased illegal drugs, Olympus, in consultation with outside legal counsel, immediately investigated the facts, made a report to the investigative authorities, and cooperated fully with their investigation," it said.
The company's board of directors then "unanimously determined" that Kaufmann "likely engaged in behaviours that were inconsistent with our global code of conduct".
Kaufmann, who is reportedly the company's second non-Japanese president, was asked to offer his resignation which the board then accepted, Olympus added.
Olympus said in 2020 it was selling its struggling camera division to focus on medical equipment. It had been in the camera business since 1936, but struggled along with industry rivals after the advent of smartphones.
The storied company has seen success in the medical equipment field, and controls much of the global endoscope market.
Olympus chairman Yasuo Takeuchi will stand in as CEO "for the time being" while the board's nominating committee considers "all options for a successor", the company said.
H.Darwish--SF-PST